Comparing single versus combination drugs for drug-resistant typhoid
Treatments studied
Part of Infections clinical trials.
This study compares giving one antibiotic versus two antibiotics to children with a hard-to-treat type of typhoid fever. The goal is to see which approach helps kids recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a child between 2 and 16 years old
- Typhoid fever confirmed by a lab test, and the bacteria do not respond to several common antibiotics
- You are admitted to Children's Hospital & Institute of Child Health in Lahore
- A parent or guardian agrees to let you take part
- You are not allergic to the study drugs (meropenem or azithromycin)
- You do not have serious health problems like heart disease, kidney failure, or a weak immune system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two strong antibiotics, meropenem (given through a vein) and azithromycin (taken by mouth), to see which one works better for a hard-to-treat type of typhoid fever called XDR (extensively drug-resistant) enteric fever. If you have been diagnosed with XDR typhoid fever, this study aims to find the best treatment option for you.
This study tests which of two antibiotic combinations works better at clearing infections caused by multi-drug-resistant bacteria in adults, including those with weakened immune systems. It aims to find a more effective treatment option.
This trial tests two different antibiotic regimens given after surgery for a ruptured appendix in children. The goal is to see which one works better to prevent infections and help children recover.
This study compares two strong antibiotics to see which one works better for people with liver failure who get a hospital-acquired infection caused by resistant bacteria. The two drugs are ceftazidime-avibactam and a higher dose of meropenem given as an extended infusion.
This trial compares two antibiotics, azithromycin and doxycycline, when given alongside a standard beta-lactam antibiotic to hospitalized adults with community-acquired pneumonia. It aims to see which combination works better and is safer.
This trial tests whether a newer antibiotic (ceftolozane/tazobactam) works as well as the standard drug (meropenem) for treating fever and low white blood cell counts in people who carry or are at risk for a certain type of resistant bacteria (ESBL). If you are colonized with ESBL or have recently used certain antibiotics, you may be eligible.
Hear when a new Typhoid Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.